Discover 199 paid clinical trials in North Dakota. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
North Dakota offers many paid research opportunities statewide, giving healthy volunteers and individuals with specific health needs access to a wide range of clinical studies. Key cities like Fargo, Bismarck, and Grand Forks are home to research centers actively recruiting participants, offering access to the latest treatments and medical advancements.
Filter
1
Filter results
Results: 199
Active & Responsive
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
for
Diabetes Mellitus, Type 2, PreDiabetes, Metabolic Syndrome
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
for
Knee Injuries, Pain, Postoperative, Opioid Use
Location: 1 recruiting location
Sponsor: Sanford Health
Sex: All
Age: 18 - 70+
Code: NCT03858231
Recruiting
Active & Responsive
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
for
Lung Cancer Diagnosis
Location: 36 recruiting locations
Sponsor: Freenome Holdings Inc.
Sex: All
Age: 50+
Code: NCT06122077
Recruiting
Active & Responsive
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
for
Chronic Granulomatous Disease (CGD)
Location: 50 recruiting locations
Sponsor: Ensoma
Sex: All
Age: 0+
Code: NCT06605378
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & ResponsiveNew
Taldefgrobep Alfa in Adults With Overweight and Obesity
for
Obesity, Overweight
Location: 17 recruiting locations
Sponsor: Biohaven Therapeutics Ltd.
Sex: All
Age: 18 - 65
Code: NCT07281495
Phase2, Recruiting
Active & ResponsiveNew
Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis
for
Atopic Dermatitis (AD), Psoriasis (PsO)
Location: 2 recruiting locations
Sponsor: LAPIX Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT06982352
Phase1, Recruiting
Active & Responsive
Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)
for
Non-small Cell Lung Cancer (NSCLC)
Location: 18 recruiting locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06305754
Phase3, Recruiting
Active & Responsive
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)
for
Carcinoma, Non-Small-Cell Lung
Location: 12 recruiting locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT04165798
Recruiting
New
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain